@josh-hardman.bsky.social on Bluesky

JavaScript RequiredThis is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is. Learn more about Bluesky at bsky.social and atproto.com.

Post

josh hardman

josh-hardman.bsky.social

did:plc:44ulwptap3wymt6lpu5fxzor

On Thursday, we broke the news that FDA had published the Complete Response Letter (CRL) it sent to Lykos Therapeutics 13 months ago today, when it rejected its MDMA for PTSD new drug application. Today, we take a much closer (~5,000 word) look... More: https://psychedelicalpha.com/news/unpacking-fdas-mdma-rejection-letter-and-the-road-ahead-for-lykos

2025-09-08T11:32:10.208Z